Evidence map›Paper›PMID 24928479›Full record

Trial reportDrug and alcohol dependence2014

Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.

Christopher D Verrico, Colin N Haile, James J Mahoney, Daisy G Y Thompson-Lake, Thomas F Newton, Richard De La Garza

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. A COMPARISON OF MAZUR'SThe Psychological record · 2017
    Article
  14. Article
  15. The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christopher D VerricoMenninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States; Department of Pharmacology, Michael E. DeBakey VA Medical Center & Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States. Electronic address: verrico@bcm.edu.
Colin N HaileMenninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States.
James J MahoneyMenninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States.
Daisy G Y Thompson-LakeMenninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States.
Thomas F NewtonMenninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States; Department of Pharmacology, Michael E. DeBakey VA Medical Center & Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States.
Richard De La GarzaMenninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States; Department of Pharmacology, Michael E. DeBakey VA Medical Center & Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States; Department of Neuroscience, Michael E. DeBakey VA Medical Center & Baylor College of Medicine, One Baylor Plaza, MS BCM350, Houston, TX 77030, United States.
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · US

Funding

Modafinil and Escitalopram for Cocaine AddictionRC1DA028387 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI DE LA GARZA, RICHARD · 2009 to 2010
$733k
NIDA NIH HHS DA028387NIDA NIH HHS RC1 DA028387
6 · The paper itself

Abstract

backgroundConcurrent administration of dopamine and serotonin reuptake inhibitors reduces cocaine self-administration in monkeys. Consonant with this, clinical trials assessing modafinil and selective serotonin reuptake inhibitors alone show some efficacy as potential pharmacotherapies for cocaine dependence. We hypothesized that combining modafinil with escitalopram would attenuate the euphoric effects of cocaine to a greater degree than modafinil alone.

methodsIn a randomized, double blind, parallel groups design participants received either placebo (0mg/day; n=16), modafinil (200mg/day; n=16), escitalopram (20mg/day; n=17), or modafinil+escitalopram (200+20mg/day; n=15) for 5 days. On day 5, during separate sessions participants received an intravenous sample of cocaine (0 or 20mg; randomized) and five $1 bills. Participants rated the subjective effects of the infusions and subsequently made choices to either return $1 and receive another infusion or keep $1 and receive no infusion.

resultsCompared to saline, cocaine (20mg) significantly (p≤0.008) increased most ratings, including "good effects", "stimulated", and "high". Relative to placebo, modafinil significantly (p≤0.007) attenuated subject-rated increases of "any drug effect", "high", "good effects", and "stimulated" produced by cocaine. Compared to saline, participants chose cocaine infusions significantly more; however, no treatment significantly reduced choices for cocaine infusions. Escitalopram did not enhance the efficacy of modafinil to reduce any measure.

conclusionsModafinil attenuated many positive subjective effects produced by cocaine; however, escitalopram combined with modafinil did not enhance the efficacy of modafinil to reduce cocaine effects.

Indexed as

AdultAffectBenzhydryl CompoundsBlood PressureChoice BehaviorCitalopramCocaineDopamine Uptake InhibitorsDouble-Blind MethodDrug InteractionsFemaleHeart RateHumansMaleMiddle AgedModafinilBenzhydryl CompoundsCitalopramCocaineDopamine Uptake InhibitorsModafinilSelective Serotonin Reuptake InhibitorsCocaineEscitalopramModafinilSubjective effects

Identifiers

PMID24928479
PMCPMC4120836
OpenAlexW2074544630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.